DOH considers mixing COVID-19 vaccines due to limited supply
The DOH is considering the possibility of administering different COVID-19 vaccine brands as second doses due to limited availability.
According to Health Undersecretary Maria Rosario Vergeire, the DOH has coordinated with the Department of Science and Technology and the Vaccine Expert Panel on this study.
Currently, only one country, the UK, is conducting trials on mixing different COVID-19 vaccine brands.
Vergeire emphasized that results from these studies are still pending.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics